Safety and Efficacy of Allogeneic Cells for the Treatment of Intermittent Claudication(IC)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Alan T Hirsch, MD
Cardiovascular Division, MMC 508, University of Minnesota Medical school, Minneapolis, MN 55455
Principal Investigator - Berthold Amann, MD
Franziskus-Krankenhaus, Berlin Germany
Principal Investigator - Bret Weichmann, MD
Florida research Network, LLC 6800NW 9th Blvd Suite1, Gainesville, Florida 32605
Principal Investigator - Changyoung Lim, MD
CHA Bundang Medical Center, CHA University, 59 Yatap-ro Bundang-Gu, Seongnam-Si, Gyeonggi-do 463-712, Korea
Principal Investigator - Christine Espinola-Klein, MD
Johannes Gutenberg University Mainz
Principal Investigator - David L Fried, MD
Omega Medical Research, Warwick, RI 02886
Principal Investigator - Dokyun Kim, MD
National Health Insurance Service Ilsan Hospital
Principal Investigator - Douglas Denham, DO
Clinical Trials of Texas, Inc. 7940 Floyd Curl drive, Suite 700, San Antonio, Texas 78229
Principal Investigator - Erwin Blessing, MD
Klinikum Karlsbad-Langensteinbach
Principal Investigator - Holger Reinecke, MD
Universitätsklinikum Münster
Principal Investigator - Jaeseung Shin, MD
Korea University
Principal Investigator - James Hampsey, MD
Tampa Bay Medical research, 3251 McMullen Booth Road, STE 303, Clearwater, FL 33761
Principal Investigator - Jeffrey W Olin, DO
Cardiovascular Institute, Mount Sinai School of Medicine , One Gustave L. Levy Place, New York, NY 10029
Principal Investigator - Joonhyuk Kong, MD
Kangbuk Samsung Hospital
Principal Investigator - Kathleen Cullen, MD
DMI Research, 6699 90th Ave. North, Pinellas Park FL
Principal Investigator - Kwangjo Cho, MD
Dong-A University Hospital
Principal Investigator - Malcolm Foster, MD
Turkey Creek Medical Center, Knoxville TN 37934
Principal Investigator - Mohler Emile, M.D
Hospital of the University of Pennsylvania, Philadelphia, PA 19104
Principal Investigator - Nadarajah Janaki, M.D
Aiyan Diabetes Center, Evans, GA 30809
Principal Investigator - Norbert Weiss, MD
Universitätsklinikum Carl Gustav Carus, Dresden, Germany
Principal Investigator - Oliver Müller, MD
Universitätsklinik Heidelberg
Principal Investigator - Reuven Zimlichman, MD
Edith Wolfson Medical Center,62 HaLohamim Street, Holon, Israel
Principal Investigator - Schulyer Jones, MD
Duke University,Durham, North Carolina, 27705, USA
Principal Investigator - Sibu P. Saha, MD
University of Kentucky, Lexington, KY 40506-0057
Principal Investigator - Sigrid Nikol, MD
ASKLEPIOS Klinik St. Georg, Hamburg Germany
Principal Investigator - Stefan Betge, MD
Jena University Hospital
Principal Investigator - Sungwon Chung, MD
Pusan National University Hospital 179 Gudeok-Ro Seo-Gu, Busan, 602-739, Korea
Principal Investigator - Thomas Zeller, MD
Universtiäts-Herzzentrum Freiburg und Bad-Krozingen
Principal Investigator - Weonyong Lee, MD
Hallym University Sacred Heart Hospital 22, Gwanpyeong-ro 170beon-gil, Dongan-gu, Anyang-si, Gyeonggi-do, 431-796, Korea
Principal Investigator - Yousun Hong, MD
Ajou University School of Medicine
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
34 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Universtiäts-Herzzentrum Freiburg Und Bad-Krozingen
Bad Krozingen, Germany
- Franziskus-Krankenhaus
Berlin, Germany
- Universitätsklinikum Carl Gustav Carus
Dresden, Germany
- Asklepios Klinik St. Georg
Hamburg, Germany
- Universitätsklinik Heidelberg
Heidelberg, Germany
- Universitätsklinikum Jena
Jena, Germany
- Srh Klinikum Karlsbad-Langensteinbach
Karlsbad, Germany
- Universitätsmedizin Der Johannes Gutenberg-Universität Mainz
Mainz, Germany
- Universitätsklinikum Münster
Münster, Germany
- "mor" Instituite, Horev M.C
Haifa, Israel
- Edith Wolson Medical Center
Holon, Israel
- Dong-A University Hospital
Seo-gu, Busan, South Korea
- Korea University Ansan Hospital
Ansan, Gyeonggi-do, South Korea
- National Health Insurance Service Ilsan Hospital
Ilsandong-gu, Goyang-si, Gyeonggi-do, South Korea
- Ajou University Hospital
Suwon, Gyeonggi-do, South Korea
- Dr. Sungwon Chung
Busan, South Korea
- Dr. Changyoung Lim
Gyeonggi-do, South Korea
- Dr. Weonyong Lee
Gyeonggi-do, South Korea
- Kangbuk Samsung Medical Center
Seoul, South Korea
- Cardiology, P. C. and Center for Therapeutic Angiogenesis
Birmingham, Alabama, United States
- Tampa Bay Medical Research
Clearwater, Florida, United States
- Florida Researc Network, Llc
Gainesville, Florida, United States
- Dmi Research
Pinellas Park, Florida, United States
- Dr. Nadarajah Janaki
Evans, Georgia, United States
- Northwestern University
Chicago, Illinois, United States
- University of Kentucky Research Foundation
Lexington, Kentucky, United States
- Cardiovascular Division, Mmc, University of Minnesota
Minneapolis, Minnesota, United States
- Cardiovascular Institute, Mount Sinai School of Medicine
New York, New York, United States
- Duke University
Durham, North Carolina, United States
- Dr. Mohler Emile
Philadelphia, Pennsylvania, United States
- Omega Medical Center
Warwick, Rhode Island, United States
- Turkey Creek Medical Center
Knoxville, Tennessee, United States
- Clinical Trials of Texas
San Antonio, Texas, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 5 Nov 2012
- Primary completion
- 29 Mar 2018
- Completion
- 9 Feb 2019
- Last update posted
- 12 Feb 2019
- Registered enrollment
- 180
- Registry id
- NCT01679990
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.